• How AIM ImmunoTech Inc. (HXB) stock performs in volatility spikes - 2025 Market Outlook & Weekly High Conviction Ideas newser.com Fri, 03 Oct 2025 10:57:29 GMT
• Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentum - Index Update & Weekly Breakout Stock Alerts newser.com Fri, 03 Oct 2025 10:37:45 GMT
• AIM: Ascendiant Capital Updates Price Target for AIM ImmunoTech | AIM Stock News GuruFocus Fri, 03 Oct 2025 10:36:38 GMT
• Will AIM ImmunoTech Inc. stock keep raising dividends - Market Volume Report & Risk Adjusted Swing Trade Ideas newser.com Fri, 03 Oct 2025 09:49:15 GMT
• Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targets - 2025 Bull vs Bear & Growth-Oriented Investment Plans newser.com Fri, 03 Oct 2025 09:10:05 GMT
• Why AIM ImmunoTech Inc. stock remains top rated - 2025 Earnings Surprises & Stepwise Trade Signal Guides newser.com Fri, 03 Oct 2025 05:13:42 GMT
• Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cuts - July 2025 Volume & Fast Gain Swing Trade Alerts newser.com Fri, 03 Oct 2025 04:33:21 GMT
• How AIM ImmunoTech Inc. stock stacks up against competitors - July 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides newser.com Fri, 03 Oct 2025 04:14:01 GMT
• How AIM ImmunoTech Inc. (HXB) stock compares with top peers - July 2025 Weekly Recap & Expert Curated Trade Ideas newser.com Wed, 01 Oct 2025 13:29:51 GMT
• Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targets - 2025 Geopolitical Influence & Low Risk Entry Point Tips newser.com Wed, 01 Oct 2025 13:15:30 GMT
• How AIM ImmunoTech Inc. (HXB) stock performs in volatility spikes - Analyst Downgrade & High Conviction Buy Zone Alerts newser.com Wed, 01 Oct 2025 11:33:02 GMT
• How AIM ImmunoTech Inc. stock stacks up against competitors - Trade Risk Report & Weekly Sector Rotation Insights newser.com Wed, 01 Oct 2025 10:01:16 GMT
• Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentum - Portfolio Value Summary & Risk Managed Investment Signals newser.com Wed, 01 Oct 2025 09:33:11 GMT
• Why AIM ImmunoTech Inc. stock remains top rated - 2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations newser.com Wed, 01 Oct 2025 01:32:41 GMT
• Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cuts - July 2025 Closing Moves & High Accuracy Swing Entry Alerts newser.com Tue, 30 Sep 2025 20:58:28 GMT
• Why AIM ImmunoTech Inc. stock remains top rated - Portfolio Return Report & Growth-Oriented Investment Plans newser.com Tue, 30 Sep 2025 06:16:04 GMT
• Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentum - Weekly Risk Report & Free Verified High Yield Trade Plans newser.com Tue, 30 Sep 2025 06:07:16 GMT
• How AIM ImmunoTech Inc. (HXB) stock compares with top peers - Trade Entry Summary & Long-Term Safe Investment Ideas newser.com Tue, 30 Sep 2025 06:02:42 GMT
• Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targets - Profit Target & Advanced Swing Trade Entry Alerts newser.com Tue, 30 Sep 2025 04:56:40 GMT
• Will AIM ImmunoTech Inc. stock keep raising dividends - Bull Run & Stepwise Swing Trade Plans newser.com Tue, 30 Sep 2025 04:29:36 GMT
• Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cuts - July 2025 Volume & Daily Entry Point Alerts newser.com Mon, 29 Sep 2025 22:29:07 GMT
• AIM ImmunoTech Secures Japan Patent for Novel Cancer Product NAVLIN DAILY Mon, 29 Sep 2025 18:12:30 GMT
• Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentum - July 2025 Review & Free Technical Pattern Based Buy Signals newser.com Mon, 29 Sep 2025 14:15:36 GMT
• How AIM ImmunoTech Inc. (HXB) stock compares with top peers - 2025 Price Action Summary & Reliable Entry Point Trade Alerts newser.com Mon, 29 Sep 2025 12:29:36 GMT
• How AIM ImmunoTech Inc. stock stacks up against competitors - 2025 AllTime Highs & Detailed Earnings Play Alerts newser.com Mon, 29 Sep 2025 09:49:09 GMT
• How AIM ImmunoTech Inc. (HXB) stock performs in volatility spikes - Market Risk Analysis & Reliable Price Action Trade Plans newser.com Mon, 29 Sep 2025 08:36:19 GMT
• Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targets - Market Activity Recap & Free Weekly Chart Analysis and Trade Gui... newser.com Mon, 29 Sep 2025 06:38:44 GMT
• Will AIM ImmunoTech Inc. stock keep raising dividends - 2025 Investor Takeaways & Short-Term Trading Alerts newser.com Sun, 28 Sep 2025 18:27:35 GMT
• Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cuts - Bull Run & Technical Pattern Recognition Alerts newser.com Sat, 27 Sep 2025 06:50:56 GMT
• how aim immunotech inc. stock stacks up against competitors - 2025 volume leaders & long-term growth stock strategies newser.com Sat, 27 Sep 2025 06:09:29 GMT
• AIM ImmunoTech Secures Japan Patent for Ampligen in Cancer Treat GuruFocus Thu, 25 Sep 2025 13:52:02 GMT
• AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint In... Yahoo Finance Thu, 25 Sep 2025 12:45:00 GMT
• Novel Cancer Therapy Patent Victory: AIM ImmunoTech's Ampligen Combo Shows Promise in Phase 2 Trials Stock Titan Thu, 25 Sep 2025 12:45:00 GMT
• aim immunotech announces publication of journal article on GlobeNewswire Tue, 23 Sep 2025 08:16:55 GMT
• aim immunotech's ampligen shows promise in cancer treatment GuruFocus Mon, 22 Sep 2025 14:07:46 GMT
• AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth Yahoo Finance Mon, 22 Sep 2025 07:00:00 GMT
• Breakthrough Cancer Treatment: AIM ImmunoTech's Ampligen + Interferon Shows Promise Against 'Cold' Tumors Stock Titan Mon, 22 Sep 2025 07:00:00 GMT
• Maxim Group Sees 133% Upside in AIM ImmunoTech Inc. (AIM) Yahoo Finance Sun, 21 Sep 2025 07:00:00 GMT
• contrasting alpha cognition (otc:acogf) & aim immunotech (nyse:aim) Defense World Sun, 21 Sep 2025 05:34:42 GMT
• 12 best fundamentally strong penny stocks to buy right now Insider Monkey Sat, 20 Sep 2025 22:53:22 GMT
• critical analysis: aim immunotech (nyse:aim) & protalix biotherapeutics (nyse:plx) Defense World Wed, 10 Sep 2025 06:24:59 GMT
• maxim group initiates aim immunotech(aim.us) with buy rating, announces target price $6 富途牛牛 Tue, 09 Sep 2025 19:36:12 GMT
• aim immunotech receives nyse american notice of delisting and appeal MSN Sun, 07 Sep 2025 07:36:47 GMT
• AIM ImmunoTech receives NYSE American notice of delisting and appeal MSN Sat, 06 Sep 2025 22:15:23 GMT
• maxim group resumes coverage with a buy rating on aim immunotech (aim) The Globe and Mail Sat, 06 Sep 2025 14:54:00 GMT
• maxim group initiates aim immunotech(aim.us) with buy rating, announces target price $6 富途牛牛 Fri, 05 Sep 2025 07:00:00 GMT
• aim immunotech highlights growing body of compelling data GlobeNewswire Fri, 05 Sep 2025 04:36:06 GMT
• aim immunotech reports positive data on ampligen for pancreatic cancer treatment AInvest Thu, 04 Sep 2025 15:03:02 GMT
• AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Pola... Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
• Breakthrough in Late-Stage Pancreatic Cancer: AIM's Ampligen Shows Survival Benefits in Phase 2 Trial Stock Titan Thu, 04 Sep 2025 07:00:00 GMT
• aim immunotech receives nyse american notice of delisting and appeal MSN Mon, 01 Sep 2025 16:44:59 GMT
• aim immunotech reports ampligen combo trial data for pancreatic cancer MSN Tue, 26 Aug 2025 22:20:29 GMT
• aim immunotech files definitive proxy statement and sends letter to shareholders Quantisnow Sat, 23 Aug 2025 20:25:09 GMT
• aim immunotech releases ceo corner segment, discusses recent progress with ampligen AInvest Fri, 22 Aug 2025 03:29:41 GMT
• AIM ImmunoTech Announces Release of the Next CEO Corner Segment Yahoo Finance Thu, 21 Aug 2025 07:00:00 GMT
• biotech aim immunotech's ceo details progress of promising pancreatic cancer drug ampligen in latest update Stock Titan Thu, 21 Aug 2025 07:00:00 GMT
• aim immunotech releases ceo corner segment, discusses recent progress with ampligen AInvest Thu, 21 Aug 2025 07:00:00 GMT
• aim immunotech's oncology gambit: can pancreatic cancer breakthroughs and financial stability fuel a biotech comeback? AInvest Sat, 16 Aug 2025 07:00:00 GMT
• AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update Yahoo Finance Fri, 15 Aug 2025 07:00:00 GMT
• Promising Pancreatic Cancer Treatment: AIM ImmunoTech's Ampligen Shows Strong Safety Data in Phase 2 Stock Titan Fri, 15 Aug 2025 07:00:00 GMT
• webull corporation shares rise 1.49% premarket after aim immunotech and moleculin biotech to present at webull financial corporate... AInvest Fri, 15 Aug 2025 07:00:00 GMT
• aim immunotech reports q2 losses amid ongoing trials, revenue down to $25k. AInvest Fri, 15 Aug 2025 07:00:00 GMT
• aim immunotech reports increased losses amid ongoing trials TipRanks Fri, 15 Aug 2025 04:41:29 GMT
• AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech Yahoo Finance Thu, 14 Aug 2025 07:00:00 GMT
• AIM ImmunoTech CEO to Share Company Updates at Webull's Biotech Investment Series Stock Titan Thu, 14 Aug 2025 07:00:00 GMT
• aim immunotech reports increased losses amid ongoing trials TipRanks Thu, 14 Aug 2025 07:00:00 GMT
• aim immunotech to present at webull financial corporate connect webinar. AInvest Thu, 14 Aug 2025 07:00:00 GMT
• aim immunotech presents at webull financial corporate connect webinar series: biotech/medtech. AInvest Thu, 14 Aug 2025 07:00:00 GMT
• aim immunotech reports ampligen combo trial data for pancreatic cancer MSN Wed, 13 Aug 2025 10:37:58 GMT
• aim immunotech’s oncology drug ampligen to be featured in GlobeNewswire Thu, 07 Aug 2025 10:58:17 GMT
• aim immunotech announces four presentations on ampligen at msci mscs-2025 TipRanks Wed, 06 Aug 2025 17:42:37 GMT
• aim immunotech's oncology drug ampligen to be featured in key pr GuruFocus Wed, 06 Aug 2025 13:18:44 GMT
• AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Skł... GlobeNewswire Wed, 06 Aug 2025 07:00:00 GMT
• Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan Wed, 06 Aug 2025 07:00:00 GMT
• aim immunotech builds positive momentum and reiterates GlobeNewswire Tue, 05 Aug 2025 03:02:55 GMT
• AIM ImmunoTech Builds Positive Momentum and Reiterates GlobeNewswire Mon, 04 Aug 2025 07:00:00 GMT
• Breakthrough in Pancreatic Cancer Treatment: AIM's Ampligen-Imfinzi Combo Shows Positive Survival Data Stock Titan Mon, 04 Aug 2025 07:00:00 GMT
• aim immunotech (aim) advances clinical trials and strengthens fi GuruFocus Mon, 04 Aug 2025 07:00:00 GMT
• aim immunotech advances clinical trials for pancreatic cancer treatment, raises $8mln in public offering. AInvest Mon, 04 Aug 2025 07:00:00 GMT
• aim immunotech surges amid key developments, raises $8 million in public offering AInvest Sun, 03 Aug 2025 07:00:00 GMT
• aim immunotech reports ampligen combo trial data for pancreatic cancer MSN Fri, 01 Aug 2025 23:15:32 GMT
• aim immunotech reports ampligen combo trial data for pancreatic cancer MSN Thu, 31 Jul 2025 10:04:41 GMT
• aim immunotech announces closing of $8.0 million public offering GlobeNewswire Thu, 31 Jul 2025 07:00:00 GMT
• aim immunotech secures $8m funding: new shares at $4.00 plus 5-year warrants Stock Titan Thu, 31 Jul 2025 07:00:00 GMT
• aim immunotech inc. completes public offering of 2,000,000 shares and warrants raising approximately $8.0 million Quiver Quantitative Thu, 31 Jul 2025 07:00:00 GMT
• aim immunotech's $8.0m capital raise: a strategic move to fuel ampligen's clinical progress and investor value? AInvest Thu, 31 Jul 2025 07:00:00 GMT
• healthcare stocks in focus: gainers and losers in tuesday's pre-market session AInvest Thu, 31 Jul 2025 07:00:00 GMT
• aim immunotech closes $8mln public offering with 2mln shares sold. AInvest Thu, 31 Jul 2025 07:00:00 GMT
• aim immunotech's stock falls 50% following $8m securities offering AInvest Wed, 30 Jul 2025 07:00:00 GMT
• aim immunotech prices 2m shares at $4.00 in public offering TipRanks Wed, 30 Jul 2025 07:00:00 GMT
• aim shares fall after pricing of $8 million public offering MarketScreener Tue, 29 Jul 2025 18:33:10 GMT
• AIM ImmunoTech reports Ampligen combo trial data for pancreatic cancer Clinical Trials Arena Tue, 29 Jul 2025 07:00:00 GMT
• AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering GlobeNewswire Tue, 29 Jul 2025 07:00:00 GMT
• AIM ImmunoTech stock plunges after pricing $8 million public offering Investing.com Tue, 29 Jul 2025 07:00:00 GMT
• AIM ImmunoTech prices $8 million public offering at $4.00 per share Investing.com Tue, 29 Jul 2025 07:00:00 GMT
• AIM ImmunoTech (AIM) Announces $8M Public Offering with New Warr GuruFocus Tue, 29 Jul 2025 07:00:00 GMT
• Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket Benzinga Tue, 29 Jul 2025 07:00:00 GMT
• aim immunotech secures fresh capital: $8m offering includes dual warrant structure at $4.00 Stock Titan Tue, 29 Jul 2025 07:00:00 GMT
• aim immunotech prices 2m shares at $4.00 in public offering TipRanks Tue, 29 Jul 2025 07:00:00 GMT
• evaluating aim immunotech's capital raise: a strategic crossroads for investors AInvest Tue, 29 Jul 2025 07:00:00 GMT
• aim immunotech announces $8 million public offering at $4 per share with accompanying warrants. AInvest Tue, 29 Jul 2025 07:00:00 GMT
• aim immunotech reports mid-year update from phase 2 study of aimpligen, imfinzi TipRanks Mon, 28 Jul 2025 13:54:23 GMT
• AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combin... Yahoo Finance Mon, 28 Jul 2025 07:00:00 GMT
• Breakthrough in Pancreatic Cancer Treatment: New Phase 2 Data Shows 64% Survival Rate at 6 Months Stock Titan Mon, 28 Jul 2025 07:00:00 GMT
• US Stocks Mixed; Enterprise Products Partners Posts Upbeat Earnings Benzinga Mon, 28 Jul 2025 07:00:00 GMT
• aim’s ampligen + imfinzi shows promise in duripanc interim update Stock Titan Mon, 28 Jul 2025 07:00:00 GMT
• aim immunotech's ampligen: a promising catalyst for shareholder value in pancreatic cancer therapy AInvest Mon, 28 Jul 2025 07:00:00 GMT
• aim immunotech says ampligen combination 'well-tolerated' in pancreatic cancer MarketScreener Mon, 28 Jul 2025 07:00:00 GMT
• aim immunotech inc. trading resumes: enhanced tools and expert analysis available for investors AInvest Mon, 28 Jul 2025 07:00:00 GMT
• aim immunotech (aim) reveals positive phase 2 ampligen pancreatic data | aim sec filing - form 8-k Stock Titan Mon, 28 Jul 2025 07:00:00 GMT
• aim immunotech (nyse:aim) stock price down 4.5% – here’s what happened Defense World Wed, 23 Jul 2025 19:15:49 GMT
• omega therapeutics (nasdaq:omga) versus aim immunotech (nyse:aim) head-to-head review Defense World Fri, 04 Jul 2025 10:21:06 GMT
• aim immunotech presents on potential of private-public partnerships for oncology TipRanks Wed, 02 Jul 2025 13:00:37 GMT
• aim immunotech inc. showcases ampligen research at u.s.-poland science and technology symposium 2025 Nasdaq Wed, 02 Jul 2025 13:00:00 GMT
• aim immunotech reveals major european expansion plan for cancer drug development Stock Titan Wed, 02 Jul 2025 07:00:00 GMT
• aim immunotech announces central irb approval of phase 2 study protocol TipRanks Tue, 24 Jun 2025 08:42:32 GMT
• how aim immunotech (nyse:aim) aligns with nyse composite biopharma pathways Kalkine Media Mon, 23 Jun 2025 07:00:00 GMT
• aim immunotech (nyse:aim) shares gap up – here’s what happened Defense World Sun, 22 Jun 2025 07:00:00 GMT
• aim immunotech faces compliance challenge over equity requiremen GuruFocus Sat, 21 Jun 2025 04:14:08 GMT
• aim immunotech announces nyse american notice of noncompliance w GuruFocus Fri, 20 Jun 2025 21:32:51 GMT
• aim immunotech receives noncompliance notification from nyse TipRanks Fri, 20 Jun 2025 21:09:59 GMT
• aim immunotech faces compliance challenge over equity requiremen GuruFocus Fri, 20 Jun 2025 20:51:25 GMT
• aim immunotech gets nyse american notice of noncompliance MarketScreener Fri, 20 Jun 2025 20:34:26 GMT
• aim immunotech inc. receives nyse american compliance warning and plans to regain compliance by june 2026 Nasdaq Fri, 20 Jun 2025 20:20:00 GMT
• aim immunotech faces nyse delisting risk: $3.9m deficit triggers second warning Stock Titan Fri, 20 Jun 2025 07:00:00 GMT
• aim immunotech's compliance crossroads: balancing risk and reward in a high-stakes gamble AInvest Fri, 20 Jun 2025 07:00:00 GMT
• aim immunotech's compliance clock ticks: can equity challenges be overcome before june 2026? AInvest Fri, 20 Jun 2025 07:00:00 GMT
• aim immunotech resumes trading on nyse american by investing.com Investing.com India Wed, 18 Jun 2025 08:47:59 GMT
• AIM ImmunoTech Inc. Common Stock Resumes Trading on NYSE American Nasdaq Tue, 17 Jun 2025 07:00:00 GMT
• AIM ImmunoTech Returns to NYSE American: What Investors Need to Know About the Stock's Exchange Comeback Stock Titan Tue, 17 Jun 2025 07:00:00 GMT
• aim immunotech resumes trading on nyse american by investing.com Investing.com Canada Tue, 17 Jun 2025 07:00:00 GMT
• Aim Immunotech CEO Thomas Equels acquires $823 in common stock Investing.com Mon, 16 Jun 2025 07:00:00 GMT
• aim immunotech announces nyse american removal of trading suspension MSN Sat, 14 Jun 2025 15:27:15 GMT
• aim immunotech ceo thomas equels acquires shares worth $896 by investing.com Investing.com Nigeria Sat, 14 Jun 2025 05:03:58 GMT
• aim immunotech ceo thomas equels acquires shares worth $896 Investing.com Fri, 13 Jun 2025 07:00:00 GMT
• aim immunotech announces nyse american removal of trading suspension MSN Fri, 13 Jun 2025 05:32:01 GMT
• AIM Immunotech announces NYSE American removal of trading suspension MSN Thu, 12 Jun 2025 12:22:28 GMT
• AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen® Yahoo Finance Thu, 12 Jun 2025 07:00:00 GMT
• NYSE American Lifts AIM ImmunoTech Trading Ban After Stock Price Recovery Stock Titan Thu, 12 Jun 2025 07:00:00 GMT
• new patent grant extends ampligen manufacturing protection for 18 years: major win for cancer and covid drug Stock Titan Thu, 12 Jun 2025 07:00:00 GMT
• aim immunotech's reverse split: a compliance catalyst for biotech value? AInvest Thu, 12 Jun 2025 07:00:00 GMT
• aim immunotech's reverse stock split: a strategic move to avoid delisting or a risky gamble? AInvest Thu, 12 Jun 2025 07:00:00 GMT
• aim immunotech announces 1-for-100 reverse stock split The Manila Times Thu, 12 Jun 2025 07:00:00 GMT
• AIM ImmunoTech Inc. Announces 1-for-100 Reverse Stock Split Effective June 12, 2025 Nasdaq Wed, 11 Jun 2025 07:00:00 GMT
• AIM ImmunoTech Sets Massive 1:100 Reverse Split to Save NYSE American Listing Stock Titan Wed, 11 Jun 2025 07:00:00 GMT
• aim immunotech announces 1-for-100 reverse stock split GlobeNewswire Wed, 11 Jun 2025 07:00:00 GMT
• aim immunotech’s drug ampligen to be tested by japan’s national institute of infectious diseases as a potential treatment for the ... ACCESS Newswire Sat, 03 May 2025 02:39:58 GMT
• aim immunotech’s ceo to present at maxim’s infectious disease virtual conference ACCESS Newswire Thu, 01 May 2025 08:12:25 GMT
• AIM ImmunoTech’s Ampligen Receives Clearance from FDA for Exportation to Argentina for the Treatment of Severe Chronic Fatigue Syn... ACCESS Newswire Tue, 29 Apr 2025 09:14:12 GMT
• aim immunotech, inc. announces pricing of $8 million public offering ACCESS Newswire Sun, 27 Apr 2025 09:54:46 GMT
• aim immunotech inc. decreases sars-cov-2 infectious viral yields by 90% using new in vitro model; supports further testing of ampl... ACCESS Newswire Sat, 26 Apr 2025 04:25:55 GMT
• top executives make bold moves with massive aim immunotech stock purchases! TipRanks Thu, 24 Apr 2025 02:24:59 GMT
• top executives make bold moves with massive aim immunotech stock purchases! TipRanks Wed, 23 Apr 2025 07:00:00 GMT
• aim immunotech announces that it will not proceed with an offering pursuant to its registration statement on form s-1 until after ... The Globe and Mail Tue, 15 Apr 2025 15:09:44 GMT
• aim immunotech inc. names ellen lintal as new chief financial officer marketscreener.com Sun, 13 Apr 2025 17:12:28 GMT
• aim immunotech receives nyse american notice of delisting and appeal MSN Sat, 12 Apr 2025 23:35:21 GMT
• aim immunotech announces trading under aimi ticker on pink open market AInvest Tue, 08 Apr 2025 07:00:00 GMT
• AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market Yahoo Finance Mon, 07 Apr 2025 07:00:00 GMT
• Aim ImmunoTech CEO Thomas K Equels buys $2,583 in common stock Investing.com Mon, 07 Apr 2025 07:00:00 GMT
• AIM ImmunoTech Changes Markets: Key Details of AIMI Ticker Switch and Special Meeting Stock Titan Mon, 07 Apr 2025 07:00:00 GMT
• aim immunotech announces trading under new ticker aimi on pink open market amid reverse split discussions AInvest Mon, 07 Apr 2025 07:00:00 GMT
• aim immunotech’s coo peter rodino iii acquires shares for $43 by investing.com Investing.com India Sat, 05 Apr 2025 07:00:00 GMT
• aim immunotech announces nyse american notice of delisting and appeal The Manila Times Sat, 05 Apr 2025 07:00:00 GMT
• aim immunotech receives nyse american notice of delisting and appeal MSN Sat, 05 Apr 2025 01:38:01 GMT
• aim immunotech receives nyse american notice of delisting and appeal MSN Fri, 04 Apr 2025 21:22:35 GMT
• AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal Yahoo Finance Fri, 04 Apr 2025 07:00:00 GMT
• nyse american suspends aim immunotech trading: company fighting delisting notice Stock Titan Fri, 04 Apr 2025 07:00:00 GMT
• nyse american to commence delisting proceedings against aim immunotech inc. (aim) Business Wire Fri, 04 Apr 2025 07:00:00 GMT
• aim immunotech faces nyse american delisting over low stock price Investing.com Fri, 04 Apr 2025 07:00:00 GMT
• dow tumbles 1,100 points; us economy adds 228,000 jobs in march Benzinga Fri, 04 Apr 2025 07:00:00 GMT
• aim immunotech’s coo peter rodino iii acquires shares for $43 Investing.com Fri, 04 Apr 2025 07:00:00 GMT
• aim immunotech inc. (amex:aim) q4 2024 earnings call transcript Insider Monkey Thu, 03 Apr 2025 07:00:00 GMT
• aim immunotech inc (aim) q4 2024 earnings call highlights: strategic advances amid financial ... Yahoo Finance Wed, 02 Apr 2025 07:00:00 GMT
• aim immunotech announces further efforts to establish clinical trials assessing ampligen as a potential protective and early-onset... ACCESS Newswire Wed, 02 Apr 2025 00:33:28 GMT
• aim immunotech inc (aim) q4 2024 earnings call highlights: strat GuruFocus Tue, 01 Apr 2025 07:00:00 GMT
• aim immunotech inc files for mixed shelf offering of up to $100 million - sec filing marketscreener.com Tue, 01 Apr 2025 07:00:00 GMT
• why xos shares are trading higher by around 9%; here are 20 stocks moving premarket Benzinga Mon, 31 Mar 2025 07:00:00 GMT
• earnings scheduled for march 28, 2025 - aim immunotech (amex:aim), china automotive systems (nasdaq:caas) Benzinga Fri, 28 Mar 2025 08:32:08 GMT
• aim immunotech made ‘significant strides’ over course of 2024 TipRanks Thu, 27 Mar 2025 13:56:48 GMT
AIM ImmunoTech Inc(NYSE MKT:AIM) 
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viruses, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for t...
Website: http://www.hemispherx.net
Founded: 1966
Full Time Employees: 24
CEO: Thomas Kenwood Equels
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends